HONDMANN, DIRK,VAN TOL, ERIC A.F.,GROSS, GABRIELE,SCHOEMAKER, MARIEKE H.,LAMBERS, TEARTSE TIM
申请号：
CA2905817
公开号：
CA2905817A1
申请日:
2014.03.11
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
The present disclosure provides a method for reducing the risk of autoimmune disease by administering a composition comprising peptides selected from a casein hydrolysate. Such a composition, may reduce the symptoms of autoimmune disease and may be a treatment for autoimmune disease, especially type 1 diabetes. Preferably, the hydrolysate consists of peptides with a molecular weight of more than 500 Da.
